EFFECTIVE FOR ALL APPLICANTS — X.D CO-LAB PILOT FUND

Terms & Policy

This document is the complete agreement governing participation in the Fund: how we handle your data, how we use your name and story, how your operational information may be used for research, and what you agree not to disclose about how this Fund works.

PART A

Terms & Privacy Policy

Applies to all applicants, from the point of application.

A.1 — Purpose and Acceptance

These Terms govern participation in the X.D Co-Lab Pilot Fund ("the Fund"), an initiative of Xpress Digital Co. ("Xpress Digital," "we," "us"). By submitting an application, you ("the Founder") agree to these Terms in full, including the Privacy Policy in A.5–A.10.

A.2 — Eligibility

By applying, you confirm that you pitched at any global accelerator/incubator and were not funded through that process; that your business is live and operating, not pre-launch; that it is based and operating in Nigeria; and that you are authorized to represent it. We may verify these facts and decline or withdraw an application at any stage if they cannot be confirmed.

A.3 — Application Process

  1. Applications are processed on a rolling basis, in batches, in the order received.
  2. You must submit, at minimum, your pitch deck, your rejection or non-selection notification, and a written statement of intended use of funds.
  3. Submission does not guarantee funding. All decisions are at the sole discretion of Xpress Digital / X.D Co-Lab.
  4. Applications close on the published deadline or once all places are filled, whichever occurs first.
  5. Decisions are final, and we are not obligated to give detailed reasons for declining an application.

A.4 — Fund Terms (Summary)

  1. Accepted Founders receive a non-dilutive grant. We take no equity, board seat, or governance right as a condition of this grant.
  2. Each grant is issued partly as cash and partly as service credit redeemable against Xpress Digital's services, as set out in the individual offer.
  3. The grant is not a loan and carries no repayment obligation.
  4. Acceptance is conditional on this entire document, including Parts B, C, and D below.

A.5 — Privacy Policy: Scope

This section explains how we collect, use, store, and protect personal data submitted during the application and grant process, in line with the Nigeria Data Protection Act, 2023 ("NDPA") and applicable Nigeria Data Protection Commission ("NDPC") guidance.

A.6 — Data We Collect

A.10 — Your Rights

Under the NDPA, you may access the personal data we hold about you, request correction of inaccurate data, request deletion (subject to our legal retention obligations), withdraw consent where processing relies on it, and lodge a complaint with the NDPC. Requests can be directed to [email protected].

PART B

Brand Association & Media Rights

Applies to accepted Founders, effective upon acceptance into the Fund.

B.1 — Grant of Rights

In consideration of the grant received, the Founder grants Xpress Digital Co. and X.D Co-Lab a non-exclusive, royalty-free right to use the Founder's business name, logo, founder name and likeness, and public-facing business milestones in: promotional materials and campaigns for the Fund; pitch decks and materials used with investors or partners; portfolio pages on Xpress Digital and X.D Co-Lab platforms; press releases and media coverage of the Fund; and Xpress Digital's content platforms, including Hortharn's Journal and the Build Forward Podcast.

B.2 — Reciprocal Right

The Founder may identify their business as "backed by X.D Co-Lab" in their own materials, including pitch decks, website, and investor communications, for the duration of this Agreement.

B.3 — Duration

This grant of rights runs for twenty-four (24) months from acceptance into the Fund, matching the service-credit redemption window. Either party may agree in writing to extend it.

B.4 — Standards of Use

Xpress Digital will not use the Founder's name, logo, or likeness in a manner that is false, defamatory, or misleading, or that implies an equity or control relationship that does not exist, and will represent the Founder's business accurately. The Founder will not represent this relationship as an equity investment or acquisition.

B.5 — No Additional Compensation

These rights are provided in consideration of the grant received; no separate fee is payable for their exercise unless otherwise agreed in writing.

B.6 — Survival

Material published in good faith during the term may continue to circulate after expiry, but no new use of the Founder's name, logo, or likeness will be made after expiry without further consent.

PART C

Case Study & Research Usage Consent

Applies to accepted Founders, effective upon acceptance into the Fund.

C.1 — Consent to Use Operational Data

The Founder consents to Xpress Digital Co. and X.D Co-Lab collecting and using operational data shared during and after participation — including growth metrics, use-of-funds outcomes, and qualitative feedback — for internal cohort analysis, educational content produced by Xpress Digital or its parent entities, and ecosystem research reports produced or co-produced by Xpress Digital or its parent entities.

C.2 — Anonymization

Where data is used for aggregate research, cohort analysis, or ecosystem reports, it will be anonymized or presented in aggregate form so the Founder's specific business is not individually identifiable, unless the Founder has separately consented to named attribution under Part B.

C.3 — Distinction from Part B

Named, attributed use of the Founder's story is governed by Part B. This Part governs the underlying operational and performance data, whether used in named or anonymized form.

C.4 — Data Accuracy

The Founder agrees to provide requested data in good faith and to the best of their knowledge. We make no warranty as to future business performance.

C.5 — Duration

This consent applies for the duration of participation in the Fund and for twenty-four (24) months thereafter, after which further use requires renewed consent.

PART D

Confidentiality & Non-Disclosure

Applies to all applicants, from the point of application, regardless of outcome.

D.1 — What Is Confidential

In the course of applying to or participating in the Fund, you may become aware of information that is not publicly disclosed by Xpress Digital Co. or X.D Co-Lab, including: the source or structure of the Fund's capital; our underwriting, evaluation, or selection criteria beyond what is published on this site; our approach to sourcing and deploying capital; the identities, applications, or terms of other applicants or founders; and any other internal, operational, or strategic information shared with you during the application or grant process ("Confidential Information").

D.2 — Why This Matters

Confidential Information of this kind is treated as proprietary to Xpress Digital Co. and X.D Co-Lab. It reflects the method by which this Fund is able to source founders, structure capital, and deploy it effectively, and its disclosure could materially disadvantage the Fund and the founders it backs.

D.3 — Your Obligation

You agree not to disclose, publish, or share Confidential Information with any third party, and to use it solely for the purpose of evaluating or participating in the Fund. This obligation applies whether or not your application is accepted.

D.4 — What This Does Not Cover

This obligation does not apply to information that is already public through no fault of yours, that you already lawfully knew before receiving it from us, that you develop independently without reference to it, or that you are required to disclose by law or a competent regulator — in which case, where legally permitted, you agree to notify us before disclosure.

D.5 — Duration

This obligation survives for as long as the relevant information remains confidential, and in any event for not less than three (3) years following the end of your participation or application process, whichever is later.

D.6 — Consequences of Breach

A breach of this Part may result in forfeiture of any unused service credit, termination of the Founder's participation in the Fund, and any other remedy available to us at law, including injunctive relief where disclosure is ongoing or imminent.

AI